Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Global Deferasirox Market Growth 2022-2028

  • LP 4711621
  • 77 Pages
  • January 2022
  • Pharmaceuticals
Download Sample    Get Discount   
 
As the global economy mends, the 2021 growth of Deferasirox will have significant change from previous year. According to our (LP Information) latest study, the global Deferasirox market size is USD million in 2022 from USD 2670.4 million in 2021, with a change of % between 2021 and 2022. The global Deferasirox market size will reach USD 3675.2 million in 2028, growing at a CAGR of 4.7% over the analysis period.

The United States Deferasirox market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Deferasirox market, reaching US$ million by the year 2028. As for the Europe Deferasirox landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.

Global main Deferasirox players cover Novartis, Cipla, Natco Pharma, and Sun Pharma, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Deferasirox market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6

500 mg/Tablet

250 mg/Tablet

125 mg/Tablet

Others

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.

Transfusional Iron Overload

NTDT Caused Iron Overload

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include

Novartis

Cipla

Natco Pharma

Sun Pharma

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Deferasirox Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Deferasirox by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Deferasirox by Country/Region, 2017, 2022 & 2028

2.2 Deferasirox Segment by Type

2.2.1 500 mg/Tablet

2.2.2 250 mg/Tablet

2.2.3 125 mg/Tablet

2.2.4 Others

2.3 Deferasirox Sales by Type

2.3.1 Global Deferasirox Sales Market Share by Type (2017-2022)

2.3.2 Global Deferasirox Revenue and Market Share by Type (2017-2022)

2.3.3 Global Deferasirox Sale Price by Type (2017-2022)

2.4 Deferasirox Segment by Application

2.4.1 Transfusional Iron Overload

2.4.2 NTDT Caused Iron Overload

2.5 Deferasirox Sales by Application

2.5.1 Global Deferasirox Sale Market Share by Application (2017-2022)

2.5.2 Global Deferasirox Revenue and Market Share by Application (2017-2022)

2.5.3 Global Deferasirox Sale Price by Application (2017-2022)

3 Global Deferasirox by Company

3.1 Global Deferasirox Breakdown Data by Company

3.1.1 Global Deferasirox Annual Sales by Company (2020-2022)

3.1.2 Global Deferasirox Sales Market Share by Company (2020-2022)

3.2 Global Deferasirox Annual Revenue by Company (2020-2022)

3.2.1 Global Deferasirox Revenue by Company (2020-2022)

3.2.2 Global Deferasirox Revenue Market Share by Company (2020-2022)

3.3 Global Deferasirox Sale Price by Company

3.4 Key Manufacturers Deferasirox Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Deferasirox Product Location Distribution

3.4.2 Players Deferasirox Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Deferasirox by Geographic Region

4.1 World Historic Deferasirox Market Size by Geographic Region (2017-2022)

4.1.1 Global Deferasirox Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Deferasirox Annual Revenue by Geographic Region

4.2 World Historic Deferasirox Market Size by Country/Region (2017-2022)

4.2.1 Global Deferasirox Annual Sales by Country/Region (2017-2022)

4.2.2 Global Deferasirox Annual Revenue by Country/Region

4.3 Americas Deferasirox Sales Growth

4.4 APAC Deferasirox Sales Growth

4.5 Europe Deferasirox Sales Growth

4.6 Middle East & Africa Deferasirox Sales Growth

5 Americas

5.1 Americas Deferasirox Sales by Country

5.1.1 Americas Deferasirox Sales by Country (2017-2022)

5.1.2 Americas Deferasirox Revenue by Country (2017-2022)

5.2 Americas Deferasirox Sales by Type

5.3 Americas Deferasirox Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Deferasirox Sales by Region

6.1.1 APAC Deferasirox Sales by Region (2017-2022)

6.1.2 APAC Deferasirox Revenue by Region (2017-2022)

6.2 APAC Deferasirox Sales by Type

6.3 APAC Deferasirox Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Deferasirox by Country

7.1.1 Europe Deferasirox Sales by Country (2017-2022)

7.1.2 Europe Deferasirox Revenue by Country (2017-2022)

7.2 Europe Deferasirox Sales by Type

7.3 Europe Deferasirox Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Deferasirox by Country

8.1.1 Middle East & Africa Deferasirox Sales by Country (2017-2022)

8.1.2 Middle East & Africa Deferasirox Revenue by Country (2017-2022)

8.2 Middle East & Africa Deferasirox Sales by Type

8.3 Middle East & Africa Deferasirox Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Deferasirox

10.3 Manufacturing Process Analysis of Deferasirox

10.4 Industry Chain Structure of Deferasirox

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Deferasirox Distributors

11.3 Deferasirox Customer

12 World Forecast Review for Deferasirox by Geographic Region

12.1 Global Deferasirox Market Size Forecast by Region

12.1.1 Global Deferasirox Forecast by Region (2023-2028)

12.1.2 Global Deferasirox Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Deferasirox Forecast by Type

12.7 Global Deferasirox Forecast by Application

13 Key Players Analysis

13.1 Novartis

13.1.1 Novartis Company Information

13.1.2 Novartis Deferasirox Product Offered

13.1.3 Novartis Deferasirox Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Novartis Main Business Overview

13.1.5 Novartis Latest Developments

13.2 Cipla

13.2.1 Cipla Company Information

13.2.2 Cipla Deferasirox Product Offered

13.2.3 Cipla Deferasirox Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Cipla Main Business Overview

13.2.5 Cipla Latest Developments

13.3 Natco Pharma

13.3.1 Natco Pharma Company Information

13.3.2 Natco Pharma Deferasirox Product Offered

13.3.3 Natco Pharma Deferasirox Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Natco Pharma Main Business Overview

13.3.5 Natco Pharma Latest Developments

13.4 Sun Pharma

13.4.1 Sun Pharma Company Information

13.4.2 Sun Pharma Deferasirox Product Offered

13.4.3 Sun Pharma Deferasirox Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Sun Pharma Main Business Overview

13.4.5 Sun Pharma Latest Developments

14 Research Findings and Conclusion

List of Tables

Table 1. Deferasirox Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Deferasirox Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of 500 mg/Tablet

Table 4. Major Players of 250 mg/Tablet

Table 5. Major Players of 125 mg/Tablet

Table 6. Major Players of Others

Table 7. Global Deferasirox Sales by Type (2017-2022) & (M Tablets)

Table 8. Global Deferasirox Sales Market Share by Type (2017-2022)

Table 9. Global Deferasirox Revenue by Type (2017-2022) & ($ million)

Table 10. Global Deferasirox Revenue Market Share by Type (2017-2022)

Table 11. Global Deferasirox Sale Price by Type (2017-2022) & (USD/Tablet)

Table 12. Global Deferasirox Sales by Application (2017-2022) & (M Tablets)

Table 13. Global Deferasirox Sales Market Share by Application (2017-2022)

Table 14. Global Deferasirox Revenue by Application (2017-2022)

Table 15. Global Deferasirox Revenue Market Share by Application (2017-2022)

Table 16. Global Deferasirox Sale Price by Application (2017-2022) & (USD/Tablet)

Table 17. Global Deferasirox Sales by Company (2020-2022) & (M Tablets)

Table 18. Global Deferasirox Sales Market Share by Company (2020-2022)

Table 19. Global Deferasirox Revenue by Company (2020-2022) ($ Millions)

Table 20. Global Deferasirox Revenue Market Share by Company (2020-2022)

Table 21. Global Deferasirox Sale Price by Company (2020-2022) & (USD/Tablet)

Table 22. Key Manufacturers Deferasirox Producing Area Distribution and Sales Area

Table 23. Players Deferasirox Products Offered

Table 24. Deferasirox Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 25. New Products and Potential Entrants

Table 26. Mergers & Acquisitions, Expansion

Table 27. Global Deferasirox Sales by Geographic Region (2017-2022) & (M Tablets)

Table 28. Global Deferasirox Sales Market Share Geographic Region (2017-2022)

Table 29. Global Deferasirox Revenue by Geographic Region (2017-2022) & ($ millions)

Table 30. Global Deferasirox Revenue Market Share by Geographic Region (2017-2022)

Table 31. Global Deferasirox Sales by Country/Region (2017-2022) & (M Tablets)

Table 32. Global Deferasirox Sales Market Share by Country/Region (2017-2022)

Table 33. Global Deferasirox Revenue by Country/Region (2017-2022) & ($ millions)

Table 34. Global Deferasirox Revenue Market Share by Country/Region (2017-2022)

Table 35. Americas Deferasirox Sales by Country (2017-2022) & (M Tablets)

Table 36. Americas Deferasirox Sales Market Share by Country (2017-2022)

Table 37. Americas Deferasirox Revenue by Country (2017-2022) & ($ Millions)

Table 38. Americas Deferasirox Revenue Market Share by Country (2017-2022)

Table 39. Americas Deferasirox Sales by Type (2017-2022) & (M Tablets)

Table 40. Americas Deferasirox Sales Market Share by Type (2017-2022)

Table 41. Americas Deferasirox Sales by Application (2017-2022) & (M Tablets)

Table 42. Americas Deferasirox Sales Market Share by Application (2017-2022)

Table 43. APAC Deferasirox Sales by Region (2017-2022) & (M Tablets)

Table 44. APAC Deferasirox Sales Market Share by Region (2017-2022)

Table 45. APAC Deferasirox Revenue by Region (2017-2022) & ($ Millions)

Table 46. APAC Deferasirox Revenue Market Share by Region (2017-2022)

Table 47. APAC Deferasirox Sales by Type (2017-2022) & (M Tablets)

Table 48. APAC Deferasirox Sales Market Share by Type (2017-2022)

Table 49. APAC Deferasirox Sales by Application (2017-2022) & (M Tablets)

Table 50. APAC Deferasirox Sales Market Share by Application (2017-2022)

Table 51. Europe Deferasirox Sales by Country (2017-2022) & (M Tablets)

Table 52. Europe Deferasirox Sales Market Share by Country (2017-2022)

Table 53. Europe Deferasirox Revenue by Country (2017-2022) & ($ Millions)

Table 54. Europe Deferasirox Revenue Market Share by Country (2017-2022)

Table 55. Europe Deferasirox Sales by Type (2017-2022) & (M Tablets)

Table 56. Europe Deferasirox Sales Market Share by Type (2017-2022)

Table 57. Europe Deferasirox Sales by Application (2017-2022) & (M Tablets)

Table 58. Europe Deferasirox Sales Market Share by Application (2017-2022)

Table 59. Middle East & Africa Deferasirox Sales by Country (2017-2022) & (M Tablets)

Table 60. Middle East & Africa Deferasirox Sales Market Share by Country (2017-2022)

Table 61. Middle East & Africa Deferasirox Revenue by Country (2017-2022) & ($ Millions)

Table 62. Middle East & Africa Deferasirox Revenue Market Share by Country (2017-2022)

Table 63. Middle East & Africa Deferasirox Sales by Type (2017-2022) & (M Tablets)

Table 64. Middle East & Africa Deferasirox Sales Market Share by Type (2017-2022)

Table 65. Middle East & Africa Deferasirox Sales by Application (2017-2022) & (M Tablets)

Table 66. Middle East & Africa Deferasirox Sales Market Share by Application (2017-2022)

Table 67. Key Market Drivers & Growth Opportunities of Deferasirox

Table 68. Key Market Challenges & Risks of Deferasirox

Table 69. Key Industry Trends of Deferasirox

Table 70. Deferasirox Raw Material

Table 71. Key Suppliers of Raw Materials

Table 72. Deferasirox Distributors List

Table 73. Deferasirox Customer List

Table 74. Global Deferasirox Sales Forecast by Region (2023-2028) & (M Tablets)

Table 75. Global Deferasirox Sales Market Forecast by Region

Table 76. Global Deferasirox Revenue Forecast by Region (2023-2028) & ($ millions)

Table 77. Global Deferasirox Revenue Market Share Forecast by Region (2023-2028)

Table 78. Americas Deferasirox Sales Forecast by Country (2023-2028) & (M Tablets)

Table 79. Americas Deferasirox Revenue Forecast by Country (2023-2028) & ($ millions)

Table 80. APAC Deferasirox Sales Forecast by Region (2023-2028) & (M Tablets)

Table 81. APAC Deferasirox Revenue Forecast by Region (2023-2028) & ($ millions)

Table 82. Europe Deferasirox Sales Forecast by Country (2023-2028) & (M Tablets)

Table 83. Europe Deferasirox Revenue Forecast by Country (2023-2028) & ($ millions)

Table 84. Middle East & Africa Deferasirox Sales Forecast by Country (2023-2028) & (M Tablets)

Table 85. Middle East & Africa Deferasirox Revenue Forecast by Country (2023-2028) & ($ millions)

Table 86. Global Deferasirox Sales Forecast by Type (2023-2028) & (M Tablets)

Table 87. Global Deferasirox Sales Market Share Forecast by Type (2023-2028)

Table 88. Global Deferasirox Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 89. Global Deferasirox Revenue Market Share Forecast by Type (2023-2028)

Table 90. Global Deferasirox Sales Forecast by Application (2023-2028) & (M Tablets)

Table 91. Global Deferasirox Sales Market Share Forecast by Application (2023-2028)

Table 92. Global Deferasirox Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 93. Global Deferasirox Revenue Market Share Forecast by Application (2023-2028)

Table 94. Novartis Basic Information, Deferasirox Manufacturing Base, Sales Area and Its Competitors

Table 95. Novartis Deferasirox Product Offered

Table 96. Novartis Deferasirox Sales (M Tablets), Revenue ($ Million), Price (USD/Tablet) and Gross Margin (2020-2022)

Table 97. Novartis Main Business

Table 98. Novartis Latest Developments

Table 99. Cipla Basic Information, Deferasirox Manufacturing Base, Sales Area and Its Competitors

Table 100. Cipla Deferasirox Product Offered

Table 101. Cipla Deferasirox Sales (M Tablets), Revenue ($ Million), Price (USD/Tablet) and Gross Margin (2020-2022)

Table 102. Cipla Main Business

Table 103. Cipla Latest Developments

Table 104. Natco Pharma Basic Information, Deferasirox Manufacturing Base, Sales Area and Its Competitors

Table 105. Natco Pharma Deferasirox Product Offered

Table 106. Natco Pharma Deferasirox Sales (M Tablets), Revenue ($ Million), Price (USD/Tablet) and Gross Margin (2020-2022)

Table 107. Natco Pharma Main Business

Table 108. Natco Pharma Latest Developments

Table 109. Sun Pharma Basic Information, Deferasirox Manufacturing Base, Sales Area and Its Competitors

Table 110. Sun Pharma Deferasirox Product Offered

Table 111. Sun Pharma Deferasirox Sales (M Tablets), Revenue ($ Million), Price (USD/Tablet) and Gross Margin (2020-2022)

Table 112. Sun Pharma Main Business

Table 113. Sun Pharma Latest Developments

List of Figures

Figure 1. Picture of Deferasirox

Figure 2. Deferasirox Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Deferasirox Sales Growth Rate 2017-2028 (M Tablets)

Figure 7. Global Deferasirox Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Deferasirox Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of 500 mg/Tablet

Figure 10. Product Picture of 250 mg/Tablet

Figure 11. Product Picture of 125 mg/Tablet

Figure 12. Product Picture of Others

Figure 13. Global Deferasirox Sales Market Share by Type in 2021

Figure 14. Global Deferasirox Revenue Market Share by Type (2017-2022)

Figure 15. Deferasirox Consumed in Transfusional Iron Overload

Figure 16. Global Deferasirox Market: Transfusional Iron Overload (2017-2022) & (M Tablets)

Figure 17. Deferasirox Consumed in NTDT Caused Iron Overload

Figure 18. Global Deferasirox Market: NTDT Caused Iron Overload (2017-2022) & (M Tablets)

Figure 19. Global Deferasirox Sales Market Share by Application (2017-2022)

Figure 20. Global Deferasirox Revenue Market Share by Application in 2021

Figure 21. Deferasirox Revenue Market by Company in 2021 ($ Million)

Figure 22. Global Deferasirox Revenue Market Share by Company in 2021

Figure 23. Global Deferasirox Sales Market Share by Geographic Region (2017-2022)

Figure 24. Global Deferasirox Revenue Market Share by Geographic Region in 2021

Figure 25. Global Deferasirox Sales Market Share by Region (2017-2022)

Figure 26. Global Deferasirox Revenue Market Share by Country/Region in 2021

Figure 27. Americas Deferasirox Sales 2017-2022 (M Tablets)

Figure 28. Americas Deferasirox Revenue 2017-2022 ($ Millions)

Figure 29. APAC Deferasirox Sales 2017-2022 (M Tablets)

Figure 30. APAC Deferasirox Revenue 2017-2022 ($ Millions)

Figure 31. Europe Deferasirox Sales 2017-2022 (M Tablets)

Figure 32. Europe Deferasirox Revenue 2017-2022 ($ Millions)

Figure 33. Middle East & Africa Deferasirox Sales 2017-2022 (M Tablets)

Figure 34. Middle East & Africa Deferasirox Revenue 2017-2022 ($ Millions)

Figure 35. Americas Deferasirox Sales Market Share by Country in 2021

Figure 36. Americas Deferasirox Revenue Market Share by Country in 2021

Figure 37. United States Deferasirox Revenue Growth 2017-2022 ($ Millions)

Figure 38. Canada Deferasirox Revenue Growth 2017-2022 ($ Millions)

Figure 39. Mexico Deferasirox Revenue Growth 2017-2022 ($ Millions)

Figure 40. Brazil Deferasirox Revenue Growth 2017-2022 ($ Millions)

Figure 41. APAC Deferasirox Sales Market Share by Region in 2021

Figure 42. APAC Deferasirox Revenue Market Share by Regions in 2021

Figure 43. China Deferasirox Revenue Growth 2017-2022 ($ Millions)

Figure 44. Japan Deferasirox Revenue Growth 2017-2022 ($ Millions)

Figure 45. South Korea Deferasirox Revenue Growth 2017-2022 ($ Millions)

Figure 46. Southeast Asia Deferasirox Revenue Growth 2017-2022 ($ Millions)

Figure 47. India Deferasirox Revenue Growth 2017-2022 ($ Millions)

Figure 48. Australia Deferasirox Revenue Growth 2017-2022 ($ Millions)

Figure 49. Europe Deferasirox Sales Market Share by Country in 2021

Figure 50. Europe Deferasirox Revenue Market Share by Country in 2021

Figure 51. Germany Deferasirox Revenue Growth 2017-2022 ($ Millions)

Figure 52. France Deferasirox Revenue Growth 2017-2022 ($ Millions)

Figure 53. UK Deferasirox Revenue Growth 2017-2022 ($ Millions)

Figure 54. Italy Deferasirox Revenue Growth 2017-2022 ($ Millions)

Figure 55. Russia Deferasirox Revenue Growth 2017-2022 ($ Millions)

Figure 56. Middle East & Africa Deferasirox Sales Market Share by Country in 2021

Figure 57. Middle East & Africa Deferasirox Revenue Market Share by Country in 2021

Figure 58. Egypt Deferasirox Revenue Growth 2017-2022 ($ Millions)

Figure 59. South Africa Deferasirox Revenue Growth 2017-2022 ($ Millions)

Figure 60. Israel Deferasirox Revenue Growth 2017-2022 ($ Millions)

Figure 61. Turkey Deferasirox Revenue Growth 2017-2022 ($ Millions)

Figure 62. GCC Country Deferasirox Revenue Growth 2017-2022 ($ Millions)

Figure 63. Manufacturing Cost Structure Analysis of Deferasirox in 2021

Figure 64. Manufacturing Process Analysis of Deferasirox

Figure 65. Industry Chain Structure of Deferasirox

Figure 66. Channels of Distribution

Figure 67. Distributors Profiles

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025

The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...

  • Publish Date: June 24, 2019
  • $1050
Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts

The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...

  • Publish Date: February 18, 2019
  • $1290
Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts

The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...

  • Publish Date: December 11, 2018
  • $1390